Yang Li
- Cancer Research top 2%
- Cancer-related molecular mechanisms research 16
- MicroRNA in disease regulation 12
- Oncology top 2%
- Cancer Cells and Metastasis 16
- Cancer Immunotherapy and Biomarkers 9
- Psychiatry and Mental health top 2%
- Behavioral Neuroscience top 5%
- Molecular Biology top 2%
- RNA modifications and cancer 10
- Histone Deacetylase Inhibitors Research 9
-
- Lung Cancer Treatments and Mutations 14
- Lung Cancer Diagnosis and Treatment 9
Yang Li
266 papers receiving 5.7k citations
Peers
Comparison fields: 5 of 158
- Cancer Research 1.0k
- Oncology 1.5k
- Psychiatry and Mental health 687
- Behavioral Neuroscience 158
- Molecular Biology 2.6k
Countries citing papers authored by Yang Li
This map shows the geographic impact of Yang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Li more than expected).
Fields of papers citing papers by Yang Li
This network shows the impact of papers produced by Yang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Li. The network helps show where Yang Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yang Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 1 | |
| 6 | 2025 | 0 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 5 | |
| 9 | 2024 | 3 | |
| 10 | 2021 | 10 | |
| 11 | 2020 | 9 | |
| 12 | 2020 | 2 | |
| 13 | 2020 | 12 | |
| 14 | 2019 | 7 | |
| 15 | 2019 | 13 | |
| 16 | 2018 | 3 | |
| 17 | 2014 | 36 | |
| 18 | 2013 | 116 | |
| 19 | Effects of naringin on MAPK signal pathway in rat bone marrow mesenchymal stem cells during osteogenic differentiation | 2012 | 2 |
| 20 | Research advances in wogonin′s anti-tumor effects | 2009 | 1 |
About Yang Li
Yang Li is a scholar working on Oncology, Cancer Research and Pharmacology, having authored 291 papers that have together received 5.8k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (16 papers), Cancer-related molecular mechanisms research (16 papers), Lung Cancer Treatments and Mutations (14 papers), MicroRNA in disease regulation (12 papers), RNA modifications and cancer (10 papers), Histone Deacetylase Inhibitors Research (9 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Lung Cancer Diagnosis and Treatment (9 papers). The work is most often cited by research in Cancer Research (1.0k citations), Oncology (1.5k citations) and Psychiatry and Mental health (687 citations). Yang Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Anil K. Sood, Susan K. Lutgendorf, Charles N. Landen, Steve W. Cole, David M. Gershenson, Liz Y. Han, Premal H. Thaker, Aparna A. Kamat, Anas Younes and Xiaoying Li. Their work appears in journals such as Journal of Clinical Oncology, Oncotarget, Frontiers in Oncology, Experimental Hematology and Biomedicine & Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.